NOWDiagnostics
Springdale
About NOWDiagnostics
NOWDiagnostics develops and manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes. The company's simple diagnostic tests empower patients and caregivers with the knowledge necessary to make intelligent healthcare choices. Its ADEXUSDx product line features a lab at your fingertip, using only a single drop of blood to test for a variety of common conditions, illnesses, and diseases. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics has the potential to decrease by days the waiting period to determine test results. The company is currently offering an hCG (pregnancy) tests, two cardiac (heart attack) tests, and three toxicology tests.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $65.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2024)
- Website: nowdx.com
- Phone: +114799664530
Industries & Categories
Health Diagnostics, Manufacturing, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nowdiagnostics-93656 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.